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Natural mutants of the DE loop of the Polyomavirus (Py) major coat protein VP1 have been previously shown to display an
altered host specificity (L. Ricci, R. Maione, C. Passananti, A. Felsani, and P. Amati, 1992, J. Virol. 66, 7153–7158). To better
understand the role of this outfacing loop of the VP1 protein in Py infectivity, we constructed and characterized a Py mutant
(Py M17) harboring a deletion of 7 AA within the tip of the DE loop. The mutant virions obtained after DNA transfection were
unable to replicate and initiate early transcription in fibroblast cells. Complementation experiments performed to rescue the
deficient M17 replication by means of wt functions revealed the cis-dominance of the mutation. In situ cell fractionation
experiments demonstrated that the Py mutant, like the Py wt, enters the cells, reaches the nucleus and that both the viral DNA
and VP1 protein are found tightly bound to the nuclear matrix. These data suggest that the VP1 protein, associated to the viral
DNA, conditions early viral gene expression and that the DE loop of the protein must be involved in this process. © 2000
Academic PressINTRODUCTION
Polyomavirus (Py) initiates infection by binding to sialic
acid-containing receptors present on the surface of host
cells (Fried et al., 1981; Stehle et al., 1994; Stehle and
Harrison, 1997; Bauer et al., 1999). Then virions are in-
ternalized by receptor-mediated endocytosis into
monopinocytotic vesicles, migrate through the cytoplasm
in these vesicles, and are delivered into the nucleus by a
process of vesicle–nuclear membrane fusion (Griffith et
al., 1988). Unlike most other viruses, the uncoating of
these infecting virions only takes place after viral parti-
cles have reached the nucleus (Mackay and Consigli,
1976; Whittaker and Helenius, 1998). Uncoating interme-
diates composed of Py DNA and both viral and host
proteins have been demonstrated to be tightly associ-
ated to insoluble nuclear structures defined as the nu-
clear matrix (NM) (Winston et al., 1980). Watson and
Gralla (1987) have suggested that for the Py-related Sim-
ian Virus 40 (SV40), the attachment of viral DNA to the
NM early on after infection is mediated by the coat
proteins, and, after the viruses’ partial uncoating, both
these proteins and the DNA may remain on the matrix.
1 The first two authors contributed equally to this work.
2 On leave of absence from the Genetics and Molecular Biology
Laboratory, Hermanos Ameijeiras Hospital, Havana, Cuba.
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293The association of viral DNA to the NM is most probably
crucial for the continuation of the lytic cycle since viral
transcription and replication processes presumably take
place there (Bucker-White et al., 1980; Chen et al., 1998;
Deppert and Schirmbeck, 1995). These events are tem-
porally regulated in the course of the Py cycle of infec-
tion. Early proteins, large T, middle T, and small T anti-
gens, are synthesized before viral DNA replication and
regulate various aspects of viral infection. In particular,
large T antigen (LT) is required for the initiation of viral
DNA replication and modulates early and late transcrip-
tion (Eckhart, 1990; Deppert and Schirmbeck, 1995). After
the onset of viral replication, the late region of Py is
expressed and the capsid proteins VP1, VP2, and VP3 are
produced and assembled in the nucleus into viral parti-
cles.
In addition to its well-known function at the structural
level, the major capsid protein VP1 has been shown to
be important in several aspects of the viral life cycle.
Notably, it plays a key role during the initial interaction of
Py with host cells as it binds, through the BC and HI
outfacing loops, to the sialic acid-containing receptor
(Stehle et al., 1994; Stehle and Harrison, 1997; Bauer et
al., 1999). Punctual modifications in these loops have
been shown to alter viral tumorigenicity (Freund et al.,
1991a,b; Bauer et al., 1999). Furthermore, VP1 is able to
bind DNA in a nonspecific manner and to interact with
the NM (Moreland et al., 1991; Stamatos et al., 1987).
Another exposed loop of the VP1 protein, the DE loop, is
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294 GARCIA ET AL.involved in determining Py host specificity. Indeed, two
Py mutants deleted of two amino acids in this region
have been shown to display an altered growth spectrum
both in vitro and in vivo (Ricci et al., 1992; Mezes and
Amati, 1994).
In the present work, we extended the investigation of
the role of VP1 in the Py life cycle. We constructed and
characterized a Py mutant deleted of 7 AA in the tip of the
DE loop of VP1. We showed that this Py mutant (Py M17)
was not infectious although still able to form virions after
DNA transfection. We demonstrated that the mutant viral
particles could reach the nucleus but were unable to
initiate early transcription even though the M17 DNA
localized in the same nuclear compartments as the wild-
type (wt) ones. Mixed infection experiments with wt vi-
ruses revealed the cis-dominance of the M17 mutation.
We discuss the possible mechanisms by which the coat
protein VP1 can condition early viral gene expression.
RESULTS
Production of a Py virus deleted of 7 AA within the
DE loop of VP1
The Py mutant M17, deleted of 21 bp in the region coding
for the tip of the DE loop, was constructed using a PCR
mutagenesis procedure described under Materials and
Methods. The deleted region, which codes for AA 146–152
(TDTVNTK), encompasses the two AA deletions in the pre-
viously isolated DE loop mutants (Ricci et al., 1992). Mod-
eling analysis with the INSIGHT II program (Molecular Sim-
ulations Inc., San Diego, CA) predicted that the three-di-
mensional structure of the resulting M17 VP1 would not be
significantly altered compared to that of the wt VP1 (Fig. 1).
To produce M17 viral particles, 3T6 cells were trans-
fected with the mutant or wt viral DNA (Materials and
Methods). The time course of Py replication was first
analyzed. Total cellular DNA was extracted from the
transfected cells, digested with the EcoRI and MboI
restriction enzymes, and then probed with the entire Py
FIG. 1. Comparison between the three-dimensional structure of Py wt
VP1 (GenBank M34958 sequence) and the model structure of the M17
mutant VP1. The oval indicates the DE loop of the VP1 protein.genome in Southern blot experiments. As shown in Fig.
2A, the viral DNA replication, visualized by digestion of
a
mDNA with MboI, was observed 24 h posttransfection (h
p.t.) and appeared to continue at a similar rate until 48 h
p.t. in both wt and M17 genomes. However, after 72 h p.t.,
the amount of replicated mutant DNA had decreased,
whereas the wt DNA continued to increase until 120 h p.t.
These data indicate that after an efficient initial round of
replication, the mutant genome is no longer able to
replicate within these normally permissive cells.
In a parallel experiment, the expression of Py early and
late genes was examined by immunofluorescence with
anti-LT and anti-VP1 antibodies. As shown in Fig. 2B, at
24 and 48 h p.t., both LT and VP1 proteins were detected
in the nucleus of transfected cells, indicating that early
and late Py mutant genes are expressed in 3T6 cells.
Characterization of the mutant viral particles
The M17 viral particles produced 48 h p.t. were char-
acterized and compared to the wt ones. To test if the
FIG. 2. Viral DNA replication and gene expression in 3T6 cells
transfected with Py wt or M17 DNA. (A) Total DNA was extracted from
3T6 cells at the indicated hours posttransfection (h p.t.) and digested
with EcoRI and MboI. Five micrograms of digested DNA was analyzed
by Southern blot using as a probe the whole Py genome. The arrow
indicates the location of the whole Py DNA linearized by EcoRI. As
transfected plasmid DNA isolated from Dam1 Escherichia coli is resis-
ant to cleavage by MboI, this enzyme cuts only replicated viral DNA. (B)
mmunofluorescence micrographs showing production of LT and VP1
roteins in 3T6 cells 24 and 48 h p.t. Fixed cells were incubated with
nti-LT rat antiserum and FITC-conjugated antibody or with anti-VP1
ouse antiserum and rhodamine-conjugated antibody.
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295A PY VP1 MUTATION PREVENTING VIRAL GROWTHmutant viral DNA was correctly encapsidated, viral ly-
sates were incubated with or without the DNase I. Then
DNA was extracted from the treated lysates and ana-
lyzed by Southern blot. A Py wt viral lysate obtained 10
days p.i. was used as a control of infective particles
containing packed minichromosomes. As expected the
DNA of the control lysate was mainly in a supercoiled
state (form I); circular relaxed and linear forms (forms II
and III, respectively) were also detected (Fig. 3A). Treat-
ment of wt lysate with DNase I did not reduce the total
amount of viral DNA, confirming that at this late stage of
viral production, the great majority of viral DNA mole-
cules were fully encapsidated and protected from nucle-
ase digestion. However, following DNase I treatment, the
supercoiled form I appeared mainly converted into form
II; in the literature, however, viral DNA in packed
minichromosomes (form I) has been described as resis-
FIG. 3. Characterization of the Py wt and M17 viral particles. (A)
Protection of wt and M17 genomes from DNase I. After treatment of
viral lysates with (1) or without (2) 5 U of DNase I for 1 h at 37°C, DNA
was extracted and directly analyzed by Southern blot using as probe
the whole Py genome. The wt control corresponds to a lysate obtained
10 days p.i. (late stage of viral production). Forms I, II, and III refer to the
supercoiled, circular relaxed, and linear forms of viral DNA, respec-
tively. (B) MspI restriction pattern of wt and M17 genomes. DNA was
xtracted from viral lysates, digested with MspI, and analyzed by
Southern blot using the whole Py genome probe. An additional MspI
restriction site in the M17 genome located in the deletion junction site
caused the digestion of the 1.4-kb fragment present in the restriction
pattern of the wt genome (arrow) into two fragments of 0.8 and 0.6 kb
(arrowheads). The weaker hybridization signal of the 1.1-kb MspI frag-
ment (asterisk) is explained by the fact that the probe consists of the
whole Py genome linearized by EcoRI. Since the EcoRI site lies exactly
within the 1.1-kb MspI fragment, this fragment hybridizes with two
egions of the probe (a large of 1.06 kb and a smaller one of 72 bp),
hereas the other MspI fragments hybridize with a single region of the
robe. (C) Electron micrographs of purified viral particles stained with
% uranyl acetate. Bar: 50 nm.tant to DNase I treatment. Such a difference was attrib-
uted to the DNA extraction procedure. In the viral lysates cobtained 48 h posttransfection, forms II and III were
predominant and the proportion of form I molecules with
respect to total viral DNA was identical for both viruses
(Fig. 3A). The treatment of viral lysates with DNase I
showed that the M17 DNA was just as protected as the
wt one and that the protected forms (namely II and III)
were in the same proportions for the two viruses (Fig.
3A). With respect to the wt control lysate obtained 10
days p.i., the respective proportion of the three DNA
forms was different and the level of protection from
DNase I was decreased for both viruses. The presence
of linear transfected DNA and the early stage of viral
production in viral lysates obtained 48 h p.t. probably
explain these results.
Figure 3B shows the digestion with restriction enzyme
MspI of DNA extracted from viral lysates. Digestion with
this enzyme enables us to control and differentiate the
M17 from the wt viral DNA as the M17 genome contains
an extra MspI site with respect to that of the wt. The
morphology of wt and M17 viral particles purified by
sucrose gradient was also examined by electron micros-
copy. We observed that M17 particles were formed and
had the same appearance as the wt ones (Fig. 3C).
The M17 virus is deficient in both replication and
early transcription
To study the growth properties of the M17 virus, fibro-
blast 3T6 cells were infected with Py mutant or wt and
viral DNA replication was measured at different times p.i.
After the cells were lysed, total DNA was extracted,
digested with MspI, and analyzed by Southern blot using
the whole Py genome probe (Fig. 4). As expected, the
amount of wt DNA increased with time while M17 DNA
was visible only 6 h p.i.; later, no detectable mutant DNA
was found (Fig. 4A). These results showed that although
able to interact with 3T6 cells, the M17 viral particles
were not able to replicate within these cells. Similar
results were obtained when infection was done on the
fibroblast 3T3 cell line or on undifferentiated C2 myoblast
and F9 teratocarcinoma cell lines (data not shown).
These two later cell lines, not permissive for Py wt, were
previously shown to be permissive for two Py VP1 mu-
tants of the DE loop (Ricci et al., 1992; Mezes and Amati,
994).
To assess if the absence of M17 replication is related
o a lack of early transcription, we analyzed by Northern
lot total RNA extracted from wt and mutant-infected 3T3
ells at 8, 14, and 26 h p.i. As shown in Fig. 5, early
ranscripts were detected in Py wt-infected cells 14 h p.i.
nd the signal had increased at 26 h p.i. In contrast, no
ignal at all was ever observed in Py M17-infected cells,
ndicating that the M17 viral particles are not able to
nitiate early transcription.To determine whether the defect in M17 replication
ould be rescued by wt functions, coinfection experi-
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296 GARCIA ET AL.ments were performed in 3T6 cells with different wt/M17
ratios. The results reported in Fig. 4B showed that at a Py
wt/M17 ratio of 1/9 (left), only the input mutant DNA was
detected at 6 h p.i., while the amount of wt DNA (1 PFU)
remained under the detection level. From 72 h p.i., the
efficient replication of wt DNA allowed the detection of
its corresponding restriction fragments, whereas the mu-
tant DNA was not detected at all. At a Py wt/M17 ratio of
FIG. 4. Viral DNA replication in 3T6 cells infected with Py wt and/or
17 viral particles. (A) Total DNA was extracted from 3T6 cells infected
ith 10 PFU eq. at the indicated hours p.i.. (B) Total DNA was extracted
rom 3T6 cells coinfected with wt and M17 viruses at a ratio of 1/9 and
/5 (10 PFU eq.), at the indicated hrs p.i.; 5 mg of total DNA was
igested with MspI and analyzed by Southern blot using the whole Py
enome probe.
FIG. 5. Northern blot analysis of total RNA extracted from 3T6 cells
infected with Py wt or M17 viral particles. Mock or infected 3T6 cells (10
PFU eq.) were lysed 8, 14, and 26 h p.i., and 15 mg of extracted total
RNA was analyzed by Northern blot using a probe specific for Py early
genes. The major transcript is indicated by an arrow.5/5 (right), none of the input DNA (wt or M17) could be
visualized. Under these conditions, the wt DNA replica-
tion was well detected from 48 h p.i. Therefore unlike the
Py wt, the mutant virus failed to replicate irrespective of
the wt/M17 ratio used. No complementation of M17 rep-
lication could be obtained when cells were infected with
wt viruses 12 h before M17 infection to allow the expres-
sion of the wt early genes (data not shown). Complemen-
tation experiments were also performed in Cop18 cells, a
fibroblast cell line transformed by the whole early region
of the Py genome that constitutively expresses the T
antigens at high levels. The T antigens provided in trans
did not restore the M17 viral replication (data not shown).
These results indicate that the M17 mutation is cis-
dominant.
Cellular localization of the M17 virus during infection
To determine whether the inability of the M17 mutant
to replicate is related to its inability to reach the nucleus
and interact with the NM, we followed and compared the
localization of the viral DNA and the VP1 protein of Py wt
and M17 in the subcellular structures of 3T3 cells. We
adopted an in situ cell fractionation procedure previously
used to study the replication of SV40 (Schirmbeck and
Deppert, 1991). The procedure consists of the sequential
extraction of the different cellular components from cells
still attached to the substratum. This methodology has
the advantage of preserving the integrity of the nuclear
substructures of the cells.
An in situ fractionation of infected 3T3 cells was per-
formed at different times p.i., and the presence of viral
FIG. 6. In situ cell fractionation of 3T3 cells infected with Py wt or M17
viral particles. Infected 3T3 cells (10 PFU eq) were in situ subfraction-
ted 1.5 and 24 h p.i. as described under Materials and Methods.
ellular fractions are defined as cytonucleoplasmic fraction after Non-
det-P40 lysis (lane 1), chromatin fraction after restriction endonucle-
ses digestion (lane 2), and subsequent high salt extraction (lane 3),
uclear matrix fraction after lysis with SDS (lane 4). (A) Total DNA from
ach fraction was extracted and analyzed by Southern blot using the
hole Py genome probe. (B) Proteins from each fraction were applied
nto nitrocellulose membrane and VP1 detection was performed using
onoclonal anti-VP1 antibodies.DNA was analyzed in each of the four resulting cellular
fractions defined in Fig. 6A. As early as 1.5 h p.i., wt DNA
a
v
297A PY VP1 MUTATION PREVENTING VIRAL GROWTHwas mainly detected in the chromatin (lanes 2–3) and
NM fractions (lane 4). At 24 h p.i., i.e., after the initiation
of the viral replication, wt DNA appeared more concen-
trated in the NM fraction (lane 4) and in the soluble
cytonucleoplasmic extract (lane 1). The viral DNA
present in this last fraction probably corresponds to the
newly synthesized and encapsidated viral genomes. On
the other hand, M17 DNA showed the same localization
as the wt at 1.5 h p.i., whereas at 24 h p.i., it could no
longer be detected in any cellular fraction (Fig. 6A).
The subcellular localization of the VP1 protein was
examined in the same experiment and analyzed by slot
blot (Fig. 6B). At 1.5 h p.i., both the wt and M17 VP1
proteins were mainly found in the chromatin (lanes 2–3)
and the NM fractions (lane 4) as well as the viral ge-
nomes. At 24 h p.i., the M17 VP1 was almost not detect-
able in any fraction. In contrast, the amount of wt VP1
had increased and was associated for the most part with
the NM fraction (Fig. 6B). This result is in accordance
with data reported by Stamatos et al. (1987) demonstrat-
ing that the newly synthesized VP1 protein rapidly asso-
ciates with the NM. The slot blot analysis clearly showed
that the wt and M17 VP1 proteins localize in the same
subnuclear structures as the corresponding viral ge-
nomes.
In conclusion, the cell fractionation experiments indi-
cate that at early times p.i., the M17 virus is in fact able
to reach the nucleus and to bind to the NM; however, this
interaction is only transient.
DISCUSSION
Previous characterizations of two Py mutants of the DE
loop of VP1 suggested that the VP1 protein plays a role
in viral growth control (Ricci et al., 1992; Mezes and
Amati, 1994). In the present study, we characterized a
new Py mutant (M17) harboring a 7 AA deletion in the tip
of the DE loop, i.e., in the same region where the two
previous mutations were found. The modification intro-
duced into the VP1 protein did not interfere with viral
DNA encapsidation since particles similar to the wt ones
were produced after DNA transfection and the encapsi-
dated M17 DNA appeared to be as protected from nu-
clease treatment as the wt one. Following infection,
these particles were able to enter and migrate to the
nucleus of mouse fibroblast cells. The mutant genome
was shown to be localized in the same subnuclear frac-
tions as the wt but unable to be transcribed and repli-
cated.
It has been demonstrated that the initial step in Py
infection corresponds to the interaction of the VP1 pro-
tein, through the BC and HI loops, with specific sialylo-
ligosaccharide-containing receptors on the surface of
host cells (Fried et al., 1981; Stehle et al., 1994; Stehlend Harrison, 1997; Bauer et al., 1999). Moreover, after
iral binding to the cell membrane, VP1-induced signalslead to the transcriptional activation of the early-re-
sponse genes c-fos, c-myc, and JE (Zullo et al., 1987;
Glenn and Eckhart, 1990). Our results demonstrated that
the M17 mutant is able to enter and reach the nucleus of
host cells as efficiently as the wt virus, thus suggesting
that the lack of M17 growth is not due to an altered
interaction with the cell membrane. Furthermore, we
observed that the VP1-induced signaling events are not
a prerequisite for Py replication since wt virions directly
microinjected into the cytoplasm or the nucleus of host
cells are still able to replicate (data not shown). In the
same microinjection experiments, M17 virions did not
replicate. Therefore, the blocking of the infectious pro-
cess in the M17 mutant cannot depend on the mem-
brane-associated signaling and must occur later, after its
entry into the cells.
Once Py virions reach the nucleus, viral DNA rapidly
associates with the NM where viral transcription and
replication events are presumed to take place (Buckler-
White et al., 1980; Chen et al., 1998). Our in situ fraction-
ation experiments showed that, at early times p.i., the wt
and M17 DNA are localized in the chromatin and NM
subnuclear fractions. The same localization has been
previously described for SV40 DNA during viral replica-
tion (Schirmberck and Deppert, 1991; Deppert and
Schirmbeck, 1995). Therefore, our results indicate that it
is unlikely that the lack of M17 replication is due to an
incorrect nuclear localization.
Northern blot experiments revealed the absence of
M17 early transcripts. Moreover, we observed that the
mutant replication failed to occur both in the presence of
the wt virions and in the presence of the early T antigens
in Cop18-infected cells. These results revealed the cis-
dominance of the M17 mutation.
By in situ cell fractionation, we also demonstrated that
the VP1 protein and the Py DNA are both present in the
NM soon after infection. These results, which are in
accordance with the data reported by other groups (Win-
ston et al., 1980; Watson and Gralla, 1987), suggest that
the VP1 protein is still associated to the viral DNA when
gene expression begins. Furthermore, Brady et al. (1980)
have shown that the association of the capsid proteins to
the SV40 minichromosome enhances its transcriptional
activity in vitro, thus suggesting that the association of
VP1 to the viral DNA may influence the DNA’s ability to
be transcribed and replicated. The results concerning
the Py M17 and these observations suggest that, just like
the wt VP1, the M17 protein is associated to the viral DNA
but negatively conditions the early gene expression. The
cis-dominance of the M17 mutation and the ability of the
M17 transfected naked DNA to be transcribed and rep-
licated are in accordance with this hypothesis.
Different interpretations can be proposed to explain
the effect of the M17 VP1 mutation on the expression
of the viral genome. One possibility is that the muta-
tion of VP1 may directly decrease the accessibility of
c
w
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transcription and replication as a result of an altered
uncoating that interferes with viral chromatin decon-
densation. The decreased accessibility might also be
due to an incorrect chromatin organization of the ge-
nome during viral assembly, just as the SV40 VP1
protein that has been shown to be involved in the
spacing of nucleosomes and the closure of the gap in
the regulatory region of the viral minichromosome
(Ambrose et al., 1986; Blasquez et al., 1986). Another
explanation could be that the mutant VP1 protein in-
terferes with the genome’s expression because of its
altered interaction with cellular regulatory factors. In
fact, it has been shown that at early times postinfec-
tion, stable uncoating intermediates of high molecular
weight are present in the nucleus; these intermediates
are composed of the viral DNA, the major capsid
protein VP1, and a number of still unidentified host
proteins (Winston et al., 1980). If we hypothesize that
this complex is involved in early transcription, the 7-AA
sequence at the tip of the DE loop of VP1 must form a
part of a recognition site for regulatory factor(s) es-
sential for early gene expression. We favor this later
hypothesis since the two previously described DE loop
mutants were able to replicate in cell lines (C2 myo-
blasts and F9 teratocarcinoma cells) that were not
permissive for the Py wt, suggesting a modified ability
of these mutants to interact with regulatory factors
(Ricci et al., 1992; Mezes and Amati, 1994). The obser-
vation that the M17 does not replicate in these cell
lines suggests that the extension of the deletion in the
tip of the DE loop has modified once again the nature
of the cellular regulatory factors interacting with this
exposed VP1 loop. One of these factors interacting
with the VP1 protein has recently been identified in our
laboratory. The nuclear matrix-associated transcrip-
tion factor Yin Yang 1 (YY1) was previously known to
participate to the expression of the Py genome (Gend-
ron et al., 1996; Martelli et al., 1996; Shi et al., 1997).
We have shown that VP1 interacts, through the DE
loop, with YY1 at early times postinfection in fibro-
blasts cells (Palkova` et al., 2000). Although the VP1
site of interaction with YY1 lies just near the region
deleted in the M17 VP1, the mutant protein still coim-
munoprecipitates with this regulatory factor (unpub-
lished results). The observation that the YY1 region
interacting with VP1 does not involve the nuclear ma-
trix binding domain of the protein is consistent with the
observation that M17 can bind to the nuclear matrix.
Therefore, the YY1 protein may behave as an interme-
diate of transcriptional complexes and other regula-
tory factors probably interact with the DE loop of VP1.
The subject of our present investigations is the iden-
tification of the proteins involved in the early transcrip-
tion complex that involve the DE loop of VP1.
f
(MATERIALS AND METHODS
Plasmid constructions
The Py wt genome was cloned into the EcoRI site of
the plasmid vector pAT153 (Twigg and Sherratt, 1980) in
which the unique AseI restriction site had been removed
(pAT153DAseI-wt). The VP1 coding sequence of Py wt is
identical to the GenBank M34958 sequence except for a
single nucleotide that causes an amino acid substitution
at position 92 (Gly3Glu).
The Py M17 genome was constructed by replacement
of the 0.9-kb AseI fragment (nucleotides 2925–3835 of
the reported sequence of the Py A2 genome; Accession
No: g332752) from the recombinant plasmid
pAT153DAseI-wt with a 0.9-kb AseI-mutated cassette
carrying a deletion of 21 nucleotides within the DE loop
of the VP1 coding region (nt 3623–3643). The mutated
cassette was obtained in three steps: (i) Two different
PCR products were obtained from the amplification of Py
genome with the following primers. To amplify nt 3844–
3644, we used the forward oligonucleotide V8 (59-GAGG-
GATTAATTTGGCTACATCAGATAC-39) carrying an AseI re-
striction site (underlined letters) and the reverse oligo-
nucleotide V5 (59-GGATCCCGGGTTTGTTGAACCCATG-
CAC-39) containing a SmaI site (bold letters). To amplify
nt 3623–2919, we used the forward oligonucleotide V6
(59-GGATCCCGGGATTTCCACTCCAGTGGAA -39) carry-
ing a SmaI restriction site and the reverse oligonucleo-
tide V7 (59-TAAACATTAATTTCCAGGAAATACAGTC -39)
containing an AseI site. (ii) Both PCR products were
digested with SmaI and religated together. (iii) The re-
sulting linear fragment containing the deletion was used
as a template for a third DNA amplification by using as
primers the oligonucleotides V8 and V7; the resulting
PCR product was digested with AseI, giving rise to the
mutated cassette. The construction of the M17 genome
has introduced a unique SmaI restriction site (CCCGGG)
and an additional MspI site (CCGG) that give rise to a
digestion pattern different from that of the wt. After clon-
ing, the entire mutated cassette (carrying the 21-bp de-
letion and the added restriction sites) has been con-
trolled by sequencing.
Cells and virus stocks
Cells. Mouse 3T3 and 3T6 fibroblasts, C2 myoblasts,
F9 teratocarcinoma cell lines, and transformed 3T3 cells
stably expressing the Py early region (Cop18 cells, kindly
provided by P. Delli Bovi) were grown in Dulbecco’s
modified Eagle’s medium (DMEM) supplemented with
10% fetal calf serum (Gibco) in a 5% CO2 atmosphere.
Viral lysates. To obtain virus stocks, the viral genomes,
loned in the EcoRI site of plasmid pAT153DAseI-wt,
ere excised and religated. The Py DNA was then trans-ected into 3T6 cells using the DEAE-dextran procedure
McCutchan and Pagano, 1968). Cells were lysed 48 h
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299A PY VP1 MUTATION PREVENTING VIRAL GROWTHposttransfection by repeated freeze–thawing and cen-
trifugated 15 min at 8000 rpm. The resulting supernatant
was collected as the viral lysate.
Titration of viral lysates. The wt viral lysate was titrated
by plaque assay [plaque forming unit (PFU)], and the Py
DNA concentration of the lysate was estimated by South-
ern blot. Because the M17 particles are not infectious,
the M17 lysate was titrated according to its viral DNA
concentration.
Infection experiments were performed using a quantity
of wt and M17 DNA molecules equivalent to a wt PFU
value of 10 (PFU eq.).
Purification of viral lysates. To purify virus stocks for
electron microscopy, we used a method adapted from
the protocol of Forstova` et al. (1995). Briefly, viral particles
present in the 3T6 transfected cell lysate were pelleted
by centrifugation through a 10% sucrose cushion in
Buffer B (150 mM NaCl, 10 mM Tris–HCl, pH 7.4, 0.01 mM
CaCl2). On the other hand, the pellet obtained from the
ransfected cells was resuspended and treated with 1
/ml of neuraminidase at 37°C. After centrifugation at
000 rpm for 15 min, the supernatant was put aside and
he pellet was resuspended and incubated in 10 mM
ris–HCl, pH 8.8 for 3 h at 4°C. After a new centrifugation
t 8000 rpm for 15 min, supernatants from both neur-
minidase and Tris–HCl pH 8.8 treatments were centri-
uged in 10% sucrose cushions in Buffer B. Then, con-
entrated particles from the three sucrose cushions
ere pooled and further purified by centrifugation
hrough a sucrose gradient (10–40% in Buffer B) for 90
in at 35,000 rpm in a Beckman SW-41 rotor. Particles
ontaining fractions (checked for VP1 protein and viral
NA concentration) were dialyzed against Buffer B and
oncentrated using a high-molecular-weight polyethyl-
ne glycol (20,000 g/mol).
ndirect immunofluorescence staining
Cells were fixed with methanol–acetone (3:7 vol/vol)
nd incubated with the primary antibody. After three
ashes with phosphate-buffered saline (PBS), cells were
ncubated with the secondary fluorochrome-conjugated
ntibody and washed with PBS. The VP1 protein was
etected using anti-VP1 mouse monoclonal antibodies
Forstova` et al., 1993). The LT antigen was detected using
rat polyclonal antibodies. Goat anti-mouse IgG-rhoda-
mine-conjugated IgG fraction (Cappel) and goat anti-rat
IgG-FITC-conjugated IgG fraction (Cappel) were used as
secondary antibodies.
Electron microscopy
Purified viral preparations were adsorbed to Formvar
carbon-coated copper grids. Then viruses were stained
with 1% uranyl acetate. The preparations were observed
with a Philips EM208 electron microscope operating at
80 kV.Southern blot analysis
Total DNA was obtained from fibroblast cells after cell
lysis in 10 mM Tris–HCl (pH 8.0), 0.1 M EDTA (pH 8.0),
0.5% SDS, 200 mg/ml proteinase K, and subsequent phe-
nol–chloroform extraction. For Southern blot hybridiza-
tions, DNA was digested with the appropriate enzymes,
and restriction fragments were separated by electro-
phoresis in 1% agarose gels and transferred to Gene
Screen plus membranes (NEN Life Science Products,
Boston) as recommended by the manufacturer. Filters
were hybridized with the whole Py genome linearized by
EcoRI as described (Sambrook et al., 1989) and autora-
diography was done with Fuji Photograph Films (Tokyo,
Japan) at 270°C.
Northern blot analysis
Total RNA was prepared from fibroblast cells accord-
ing to the acid guanidinium thiocyanate–phenol–chloro-
form single step method as described by Chomczynski
and Sacchi (1987). Northern blot analysis was carried out
as previously described (Anastasi et al., 1997). The early
region probe consisted of a 1.1-kb NdeI–EcoRI fragment
of the Py genome.
In situ cell fractionation
The cell fractionation conditions were adapted from
the protocol used by Schirmbeck and Deppert (1991). 3T3
monolayers were washed with KM buffer (10 mM NaCl, 1
mM MgCl2, 2 mM DTT, 10 mg of leupeptin/ml, 10 mM
MOPS, pH 6.5) and treated for 30 min on ice in 0.3 ml of
KM buffer containing 0.5% Nonidet-P40 to obtain the
cytonucleoplasmic extract (fraction 1). To extract the cel-
lular chromatin, residual nuclear structures still attached
to the substrate were subjected to two successive treat-
ments. First, they were incubated with non-Py-cutting
restriction endonucleases SacII, BglII, XhoI, and HpaI
(100 U/ml of each) for 30 min at 37°C in restriction buffer
(100 mM NaCl, 3 mM MgCl2, 2 mM DTT, 10 mg/ml
leupeptin, 10 mM Tris–HCl, pH 7.4) to relax the chromatin
loops and to obtain the restriction endonucleases extract
(fraction 2). Then they were extracted with KM buffer
adjusted to 1.5 M NaCl (30 min on ice) to obtain the
chromatin extract (fraction 3). The residual nuclear ma-
trices were lysed in Tris–EDTA saline buffer (1% SDS, 2
mM EDTA, 20 mM Tris–HCl, pH 7.4) to obtain the fraction
4 corresponding to the nuclear matrix extract.
Two thirds of each fraction was adjusted to the same
SDS and EDTA concentrations as fraction 4 and treated
with 200 mg/ml of proteinase K. Total DNA was then
purified with a phenol–chloroform extraction, digested
with MspI, and analyzed by Southern blot. The remaining
third of each fraction, to which phenylmethylsulfonyl flu-
oride (PMSF) was added to a final concentration of 100
mg/ml, was used to detect the VP1 protein by slot blot.
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One third of each fraction obtained following the in situ
cell fractionation was applied onto a nitrocellulose mem-
brane. As the M17 VP1 protein is poorly recognized by
monoclonal anti-VP1 antibodies, the membranes were
first incubated in a denaturing Buffer B containing 50 mM
EDTA, pH 8.0, 0.1% SDS for 2 h at room temperature. After
a blocking step with 5% milk–PBS, the filters were incu-
bated with mouse monoclonal anti-VP1 antibodies (For-
stova` et al., 1993) for 30 min, washed, and then incubated
with the secondary Px-conjugated anti-mouse IgG anti-
body (Bio-Rad Laboratories, Hercules, CA). Blots were
stained with the enhanced chemiluminescence system
(ECL; Amersham International).
Data imaging
Photographic negatives were scanned into Adobe
Photoshop with an AGFA studio scanner, and the
scanned images were printed with a Hewlett Packard
Deskjet 890C color printer.
ACKNOWLEDGMENTS
We are grateful to Rene´e Favre, in whose laboratory the electron
microscopy was carried out, and Mario Fu`a for protein modeling
analysis. We thank Rossella Maione for critical reading of the manu-
script. This work was supported by a Biotechnology European Com-
munity grant (BIO4-CT97-2147) and by the Ministry of University and
Scientific Research and Technology of Italy. M.-I. Garcia is a postdoc-
toral fellow of the European Community Biotechnology program.
REFERENCES
Ambrose, C., Blasquez, V., and Bina, M. (1986). A block in initiation of
Simian virus 40 assembly results in the accumulation of minichro-
mosomes containing an exposed regulatory region. Proc. Natl. Acad.
Sci. USA 83, 3287–3291.
Anastasi, S., Giordano, S., Sthandier, O., Gambarotta, G., Maione, R.,
Comoglio, P., and Amati, P. (1997). A natural hepatocyte growth
factor/Scatter factor autocrine loop in myoblast cells and the effect of
the constitutive Met kinase activation on myogenic differentiation.
J. Cell Biol. 137, 1057–1068.
auer, P. H., Cui, C., Stehle, T., Harrison, S. C., DeCaprio, J. A., and
Benjamin, T. L. (1999). Discrimination between sialic acid-containing
receptors and pseudoreceptors regulates Polyomavirus spread in
the mouse. J. Virol. 73, 5826–5832.
lasquez, V., Stein, A., Ambrose, C., and Bina, M. (1986). Simian virus 40
protein VP1 is involved in spacing nucleosomes in minichromo-
somes. J. Mol. Biol. 191, 97–106.
rady, J. N., Lavialle, C., and Salzman, N. P. (1980). Efficient transcription
of a compact nucleoprotein complex isolated from purified Simian
virus 40 virions. J. Virol. 35, 371–381.
uckler-White, A. J., Humphrey, G. W., and Pigiet, V. (1980). Association
of Polyoma T antigen and DNA with the nuclear matrix from lytically
infected 3T6 cells. Cell 22, 37–46.
Chen, L.-F., Ito, K., Murakami, Y., and Ito, Y. (1998). The capacity of
Polyomavirus enhancer binding protein 2aB (AML1/Cbfa2) to stimu-
late Polyomavirus DNA replication is related to its affinity for the
nuclear matrix. Mol. Cell. Biol. 18, 4165–4176.
homczynski, P., and Sacchi, N. (1987). Single step method of RNA
isolation by acid guanidium thiocyanate-phenol-chloroform extrac-
tion. Anal. Biochem. 162, 156–159.eppert, W., and Schirmbeck, R. (1995). The nuclear matrix and virus
function. In “Nuclear Matrix: Structural and Functional Organization”
(R. Berezney and W. J. Kwang, Eds.), pp.485–537. Academic Press,
San Diego.
ckhart, W. (1990). Polyomavirinae and their replication. In “Virology”
(B. N. Fields, D. M. Knipe, et al., Eds.), 2nd ed., pp.1593–1607. Raven
Press, NY.
orstova`, J., Krauzewicz, N., Sandig, V., Elliott, J., Palkova, Z., Strauss, M.,
and Griffin, B. E. (1995). Polyoma virus pseudocapsids as efficient
carriers of heterologous DNA into mammalian cells. Hum. Gene
Ther. 6, 297–306.
orstova`, J., Krauzewicz, N., Wallace, S., Street, A. J., Dilworth, S. M.,
Beard, S., and Griffin, B. E. (1993). Cooperation of structural proteins
during late events in the life cycle of polyomavirus. J. Virol. 67,
1405–1413.
reund, R., Calderone, A., Dawe, C. J., and Benjamin, T. L. (1991).
Polyomavirus tumor induction in mice: Effects of polymorphisms of
VP1 and large T antigen. J. Virol. 65, 335–341a.
reund, R., Garcea, R. L., Sahli, R., and Benjamin, T. L. (1991). A
single-amino-acid substitution in Polyomavirus VP1 correlates with
plaque size and hemagglutination behavior. J. Virol. 65, 350–355b.
ried, G., Cahan, L. D., and Paulson, J. C. (1981). Polyoma virus recog-
nizes specific sialyloligosaccharide receptors on host cells. Virology
109, 188–192.
endron, D., Delbecchi, L., Bourgaux-Ramoisy, D., and Bourgaux, P.
(1996). An enhancer of recombination in Polyomavirus DNA. J. Virol.
70, 4748–4760.
lenn, G. M., and Eckhart, W. (1990). Transcriptional regulation of
early-response genes during Polyomavirus infection. J. Virol. 64,
2193–2201.
Griffith, G. R., Marriott, S. G., Rintoul, D. A., and Consigli, R. A. (1988).
Early events in Polyomavirus infection: Fusion of monopinocytotic
vesicles containing virions with mouse kidney cell nuclei. Virus Res.
10, 41–52.
Mackay, R. L., and Consigli, R. A. (1976). Early events in Polyoma virus
infection: Attachment, penetration, and nuclear entry. J. Virol. 19,
620–636.
Martelli, F., Iacobini, C., Caruso, M., and Felsani, A. (1996). Character-
ization of two novel YY1 binding sites in the polyomavirus late
promoter. J. Virol. 70, 1433–1438.
McCutchan, J. H., and Pagano, J. S. (1968). Enhancement of the infec-
tivity of simian virus 40 deoxyribonucleic acid with diethylaminoethyl-
dextran. J. Natl. Cancer Inst. 41, 351–357.
Mezes, B., and Amati, P. (1994). Mutations of Polyomavirus VP1 allow in
vitro growth in undifferentiated cells and modify in vivo tissue repli-
cation specificity. J. Virol. 68, 1196–1199.
Moreland, R. B., Montross, L., and Garcea, R. L. (1991). Characterization
of the DNA-binding properties of the Polyomavirus capsid protein
VP1. J Virol. 65, 1168–1176.
Palkova`, Z., Spanielova`, H., Gottifredi, V., Hollanderova`, D., Forstova`, J.,
and Amati, P. (2000). The Polyomavirus major capsid protein VP1
interacts with the nuclear matrix regulatory protein YY1. FEBS Lett.
467, 359–364.
Ricci, L., Maione, R., Passananti, C., Felsani, A., and Amati, P. (1992).
Mutations in the VP1 coding region of Polyomavirus determine dif-
ferentiating stage specificity. J. Virol. 66, 7153–7158.
Sambrook, J., Fritsch, E. F., and Maniatis, T. (1989). “Molecular Cloning:
A Laboratory Manual,” 2nd ed. Cold Spring Harbor Laboratory Press,
Cold Spring Harbor, NY.
Schirmbeck, R., and Deppert, W. (1991). Structural topology of simian
virus 40 DNA replication. J. Virol. 65, 2578–2588.
Shi, Y., Lee, J.-S., and Galvin, K. M. (1997). Everything you have ever
wanted to know about Yin Yang 1. Biochim Biophys. Acta 1332,
F49–F66.Stamatos, N. M., Chakrabarti, S., Moss, B., and Hare, J. D. (1987).
Expression of Polyomavirus virion proteins by a vaccinia virus vector:
301A PY VP1 MUTATION PREVENTING VIRAL GROWTHAssociation of VP1 and VP2 with the nuclear framework. J. Virol. 61,
516–525.
Stehle, T., and Harrison, S. C. (1997). High-resolution structure of a
Polyomavirus VP1-oligosaccharide complex: Implications for assem-
bly and receptor binding. EMBO J. 16, 5139–5148.
Stehle, T., Yan, Y., Benjamin, T. L., and Harrison, S. C. (1994). Structure
of murine Polyomavirus complexed with an oligosaccharide receptor
fragment. Nature 369, 160–163.
Twigg, A. J., and Sherratt, D. (1980). Trans-complementable copy-num-
ber mutants of plasmid ColE1. Nature 283, 216–218.
Watson, J. B., and Gralla, J. D. (1987). Simian virus 40 associates withnuclear superstructures at early times of infection. J. Virol. 61, 748–
754.
Whittaker, G. R., and Helenius, A. (1998). Nuclear import and export of
viruses and virus genomes: Minireview. Virology 246, 1–23.
Winston, V. D., Bolen, J. B., and Consigli, R. A. (1980). Isolation and
characterization of Polyoma uncoating intermediates from the nuclei
of infected mouse cells. J. Virol. 33, 1173–1181.
Zullo, J., Stiles, C. D., and Garcea, R. L. (1987). Regulation of c-myc and
c-fos mRNA levels by polyomavirus: Distinct roles for the capsid
protein VP1 and the viral early proteins. Proc. Natl. Acad. Sci. USA 84,
1210–1214.
